BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32034983)

  • 1. Poor response to hepatitis A vaccination in hematopoietic stem cell transplant recipients.
    Adati EM; da Silva PM; Sumita LM; Rodrigues MO; Zanetti LP; Dos Santos ACF; de Souza MP; Colturato VR; Machado CM
    Transpl Infect Dis; 2020 Jun; 22(3):e13258. PubMed ID: 32034983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of hepatitis A vaccination in kidney transplant recipients.
    Jeon HJ; Ro H; Jeong JC; Koo TY; Han M; Min SI; Oh KH; Ha J; Ahn C; Yang J
    Transpl Infect Dis; 2014 Jun; 16(3):511-5. PubMed ID: 24750343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of booster vaccination with a virosomal hepatitis A vaccine after primary immunization with an aluminum-adsorbed hepatitis A vaccine.
    Beck BR; Hatz CF; Loutan L; Steffen R
    J Travel Med; 2004; 11(4):201-6. PubMed ID: 15541221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
    Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
    J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological responses to revaccination with hepatitis A virus (HAV) vaccines among HIV-positive individuals whose anti-HAV antibody waned after primary vaccination.
    Chen GJ; Sun HY; Lin KY; Cheng A; Huang YC; Hsieh SM; Sheng WH; Liu WC; Hung CC; Chang SC
    Liver Int; 2018 Jul; 38(7):1198-1205. PubMed ID: 29240985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9-10 year-old girls according to 0-6 month schedule.
    Gilca V; Sauvageau C; Boulianne N; De Serres G; Couillard M; Krajden M; Ouakki M; Murphy D; Trevisan A; Dionne M
    Hum Vaccin Immunother; 2014; 10(8):2438-45. PubMed ID: 25424952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interchangeability of a hepatitis A vaccine second dose: Avaxim 80 following a first dose of Vaqta 25 or Havrix 720 in children in Turkey.
    Soysal A; Gokçe I; Pehlivan T; Bakir M
    Eur J Pediatr; 2007 Jun; 166(6):533-9. PubMed ID: 17318620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine.
    Van Damme P; Leroux-Roels G; Suryakiran P; Folschweiller N; Van Der Meeren O
    Hum Vaccin Immunother; 2017 May; 13(5):972-980. PubMed ID: 28281907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of immunity after hepatitis A vaccination in HIV-infected persons.
    Overton ET; Nurutdinova D; Sungkanuparph S; Seyfried W; Groger RK; Powderly WG
    J Viral Hepat; 2007 Mar; 14(3):189-93. PubMed ID: 17305885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single dose of inactivated hepatitis A vaccine promotes HAV-specific memory cellular response similar to that induced by a natural infection.
    Melgaço JG; Morgado LN; Santiago MA; Oliveira JM; Lewis-Ximenez LL; Hasselmann B; Cruz OG; Pinto MA; Vitral CL
    Vaccine; 2015 Jul; 33(32):3813-20. PubMed ID: 26144899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with Diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines in children 15 months of age.
    Trofa AF; Klein NP; Paul IM; Michaels MG; Goessler M; Chandrasekaran V; Blatter M
    Pediatr Infect Dis J; 2011 Sep; 30(9):e164-9. PubMed ID: 21494175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Need for vaccination of susceptible food handlers against hepatitis A in Taiwan.
    Yu MI; Lee SD; Lu RH; Chan CY; Wang YJ; Chang FY; Lo KJ
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Nov; 63(11):798-803. PubMed ID: 11155755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of hepatitis A vaccine immunity in a cohort of human immunodeficiency virus-infected children living in Switzerland.
    Crisinel PA; Posfay-Barbe KM; Aebi C; Cheseaux JJ; Kahlert C; Rudin C; Nadal D; Siegrist CA;
    Clin Vaccine Immunol; 2012 Nov; 19(11):1751-7. PubMed ID: 22933400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years.
    Van Herck K; Jacquet JM; Van Damme P
    J Med Virol; 2011 Nov; 83(11):1885-91. PubMed ID: 21915861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine induced Hepatitis A and B protection in children at risk for cystic fibrosis associated liver disease.
    Shapiro AJ; Esther CR; Leigh MW; Dellon EP
    Vaccine; 2013 Jan; 31(6):906-11. PubMed ID: 23261047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological priming of one dose of inactivated hepatitis A vaccine given during the first year of life in presence of maternal antibodies.
    Lagos R; Munoz A; Dumas R; Pichon S; Zambrano B; Levine M; Vidor E
    Vaccine; 2003 Sep; 21(25-26):3730-3. PubMed ID: 12922104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines - A systematic review.
    Stuurman AL; Marano C; Bunge EM; De Moerlooze L; Shouval D
    Hum Vaccin Immunother; 2017 Mar; 13(3):724-736. PubMed ID: 27786671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seventeen-year antibody persistence in adults primed with two doses of an inactivated hepatitis A vaccine.
    Van Herck K; Crasta PD; Messier M; Hardt K; Van Damme P
    Hum Vaccin Immunother; 2012 Mar; 8(3):323-7. PubMed ID: 22327499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of hepatitis A virus in Mumbai, and immunogenicity and safety of hepatitis A vaccine.
    Dhawan PS; Shah SS; Alvares JF; Kher A; Shankaran ; Kandoth PW; Sheth PN; Kamath H; Kamath A; Koppikar GV; Kalro RH
    Indian J Gastroenterol; 1998 Jan; 17(1):16-8. PubMed ID: 9465507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis A epidemiology in Latin American countries: a 2020 view from a systematic literature review.
    Andani A; van Elten TM; Bunge EM; Marano C; Salgado F; Jacobsen KH
    Expert Rev Vaccines; 2020 Sep; 19(9):795-805. PubMed ID: 32955965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.